High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/2194036

J. Natl. Cancer Inst. 1990 Jul 18 82 14 1202-6

Download in:

View as

Triples

General Info

PMID
2194036